Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Growth in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 141,900 shares, an increase of 27.2% from the January 15th total of 111,600 shares. Approximately 11.4% of the company’s shares are short sold. Based on an average trading volume of 401,600 shares, the short-interest ratio is currently 0.4 days.

Autonomix Medical Stock Down 0.4 %

AMIX traded down $0.01 on Friday, hitting $2.84. The company had a trading volume of 12,677 shares, compared to its average volume of 337,608. Autonomix Medical has a 12-month low of $2.55 and a 12-month high of $99.60. The company has a current ratio of 4.26, a quick ratio of 4.26 and a debt-to-equity ratio of 0.36. The business’s fifty day simple moving average is $3.10 and its 200 day simple moving average is $8.83.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings results on Thursday, February 13th. The company reported ($1.46) EPS for the quarter. As a group, equities research analysts predict that Autonomix Medical will post -10 earnings per share for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.